Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 WuXi PharmaTech to Build Third Mfg. Facility for Cell Therapies | Contract Pharma

What are you searching for?

Sign in
Breaking News

WuXi PharmaTech to Build Third Mfg. Facility for Cell Therapies

Will provide cGMP manufacture for clinical and commercial supply

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi PharmaTech is building a new, 145,000-sq.-ft. cGMP facility in Philadelphia for the manufacture of cell therapies. This facility will contain viral vectors such as chimeric antigen receptor T cell (CAR T cell) therapies, which are T cells harvested from a patient’s body, engineered to target specific cancers, and then reintroduced into the body. The company currently has a facility for biological safety and lot release testing in Philadelphia.
 
This will be WuXi’s third cell therapy manufacturing facility when operational in mid-2016. It will provide contract development and cGMP manufacturing capabilities for clinical studies and commercial supply to support industry’s unique requirements in this growing area. By 2016, WuXi will have 206,000 sq.-ft. of manufacturing capacity in the U.S. for clinical and commercial production of cell therapies. 
 
“Cell therapies like CAR T cells offer important new treatment options for cancer patients, and WuXi aims to be at the forefront of this area of providing our partners with cutting-edge cGMP manufacturing capabilities and capacities,” said Dr. Ge Li, chairman and chief executive officer of WuXi PharmaTech.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics